The startup manufactures pre-clinical medical devices designed for mechanical thrombectomy, specifically targeting the removal of clots and facilitating revascularization in patients with acute ischemic strokes. Their technology enables timely intervention, improving patient outcomes by restoring blood flow effectively.
Funding
Funding not disclosed
Founders
Product
Problem
Acute ischemic strokes require rapid intervention to restore blood flow and minimize brain damage, but current mechanical thrombectomy devices may not always be effective in quickly and completely removing clots. This can lead to incomplete revascularization and poorer patient outcomes.
Solution
Julier Medical is developing pre-clinical medical devices designed to improve the speed and efficacy of mechanical thrombectomy procedures for acute ischemic stroke patients. Their technology aims to facilitate more complete clot removal and faster revascularization, ultimately leading to improved neurological outcomes. The devices are being engineered to address the challenges associated with navigating complex vasculature and retrieving various types of thrombi.
Target Audience
The primary target audience includes interventional neurologists and neurosurgeons who perform mechanical thrombectomy procedures for patients experiencing acute ischemic stroke.
Features
- Devices designed for mechanical thrombectomy
- Focus on clot removal and revascularization